Evidence map›Paper›PMID 25994184›Full record

ArticleCardiovascular diabetology2015

Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes.

Camilla Vavruch, Toste Länne, Mats Fredrikson, Torbjörn Lindström, Carl Johan Östgren, Fredrik H Nystrom

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01049737 (Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01049737 completednot on this map

Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care

TypeobservationalSponsorLinkoeping UniversityRan2005 to 2012Enrolled761ConditionsDiabetes Mellitus Type 2, Cardiovascular Diseases
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Camilla VavruchDepartment of Medical and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden. camilla.vavruch@gmail.com.
Toste LänneDepartment of Medical and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden. toste.lanne@liu.se.
Mats FredriksonDepartment of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. mats.fredrikson@liu.se.
Torbjörn LindströmDepartment of Medical and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden. torbjorn.lindstrom@lio.se.
Carl Johan ÖstgrenDepartment of Medical and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden. carl.johan.ostgren@liu.se.
Fredrik H NystromDepartment of Medical and Health Sciences, Linköping University, SE 581 85, Linköping, Sweden. fredrik.h.nystrom@liu.se.
Linköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew and clinically useful markers of cardiovascular risk are of essence in type 2 diabetes since ischemic heart disease is a major cause of death in these patients.

methodsWe analyzed baseline data from 476 men and 244 women who participated in "Cardiovascular Risk factors in Patients with Diabetes -a Prospective study in Primary care" study. All participants had type 2 diabetes and were 55-66 years old at recruitment during year 2005 to 2008. Except for established traditional risk markers for vascular disease, we also estimated vascular complications non-invasively by performance of carotid-femoral pulse-wave velocity (PWV, with applanation-tonometry) and intima-media thickness of carotid arteries (IMT, with B-mode ultrasound). Patients were followed for incidence of ischemic heart disease mortality and morbidity until end of the year 2012, using the national Swedish Cause of Death and Hospitalization Registries.

resultsDuring the follow-up period of a median of 6 years 47 men and 10 women died or were hospitalized for ischemic heart disease including myocardial infarction. Leptin levels were positively related to the hazard ratio (HR) in men (HR for each log 10 unit 4.9, CI 1.99 to 11.8) and women (HR 11.5, CI 1.47 to 89.7). Leptin predicted ischemic heart disease independently of age, HbA1c, BMI, systolic blood pressure and LDL-cholesterol/HDL-cholesterol ratio (men: HR 12.9 CI 3.2-53, women: HR 19.9, CI 1.2-327) This finding of increased risk related to high leptin levels was also statistically significant when carotid-femoral PWV and IMT were both added to the equations in men (hazard ratio 9.2 CI 2.1-41).

conclusionsOur data support the use of serum leptin in type 2 diabetes to add independent prognostic information in terms of ischemic heart disease when compared with traditional cardiovascular risk factors. In the men of the cohort this prognostic information was in addition also to data on IMT and PWV, two non-invasive measurements of the extent of vascular disease. The power to detect a similar relationship in women was less strong due to lower incidence of cardiovascular disease.

trial registrationClinicalTrials.gov: NCT01049737.

Indexed as

Carotid ArteriesCarotid Intima-Media ThicknessCohort StudiesDiabetes Mellitus, Type 2FemaleHumansIncidenceLeptinLongitudinal StudiesMaleMiddle AgedMyocardial InfarctionMyocardial IschemiaPrognosisProportional Hazards ModelsProspective StudiesLeptin

Identifiers

PMID25994184
PMCPMC4460770
OpenAlexW2137085246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.